Informazioni su StandardX
StandardX sta progettando una piattaforma compatta di accelerazione di particelle ad alta potenza, pensata per produrre diversi isotopi con un impianto standardizzato. Fondata nel 2025, inizialmente si concentra sulla fornitura di isotopi per la diagnosi e il trattamento dei tumori, la ricerca e i futuri sistemi a fusione.
What StandardX offers
StandardX is developing a scalable production platform for rare isotopes used in medicine, industry and energy. Its compact particle-accelerator architecture is intended to produce a versatile portfolio including diagnostic and therapeutic medical isotopes, industrial isotopes and tritium for fusion energy.
What sets StandardX apart
StandardX is building a repeatable isotope-production platform rather than a facility dedicated to a single isotope. The compact accelerator architecture is designed to translate specialised nuclear physics into distributed, scalable production for materials that are currently scarce or constrained by centralised supply.